A REVIEW ON NEW DRUG APPROVAL PROCESS IN INDIA
Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 7
Abstract
A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch a drug in the market, is known as drug approval process. In general, a drug approval process comprises of various stages: application to conduct clinical trials, conducting clinical trials, application to marketing authorization of drug and post-marketing studies. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate the marketing of the drugs. This work focuses on the drug approval process in India. The new drug approval process in India is standardized and well controlled, involving multiple steps and organizations. At the central level, DCGI, under the Ministry of Health and Family Welfare, approves the drug or medical device for marketing. Manufacturing licenses are approved at the state level by state drug control authorities. Monitoring is also performed by state agencies in coordination with the CDSCO.
Authors and Affiliations
Pooja Agarwal
GC-MS ANALYSIS AND ANTIMICROBIAL ACTIVITY OF SUDANESE PETROSELINUM CRISPUM(MILL) NYMAN EX AW HILL (APIACEAE) ESSENTIAL OIL
Information on the phytoconstituents of medicinal plants used traditionally in Sudan is very scarce. Hence this study was set to investigate the chemical constituents of the medicinally important species Petroselinum cri...
PHYTOCHEMICAL ANALYSIS AND ISOLATION OF COMPOUNDS FROM METHANOLIC LEAF EXTRACT OF AMARANTHUS SPINOSUS AND ITS ANTIMICROBIAL EFFECT AGAINST STAPHYLOCOCCUS AUREUS
The crushed leaf of Amaranthus spinosus is used to treat skin infections and wound. The leaves are boiled without salt and consumed for 2-3 days to cure jaundice. Recent studied showed that Amaranthus leaves contain vari...
PREVALENCE OF NEONATAL CANDIDEMIA IN TERTIARY CARE INSTITUTE, INDORE
Background: Candida spp.is one of the most frequent pathogens isolated in bloodstream infections (BSI), and is associated with significant morbidity and mortality in hospitalized patients1 .Candida species are known to b...
AN ARTICLE ON COUNTERFEIT MEDICINES ('PEOPLE ARE DYING EVERY DAY')
The proliferation of counterfeit and poor-quality medicines is a major public health problem, especially in developing countries lacking adequate resources to effectively monitor their prevalence. Industrialized countrie...
PATTERN OF ANTIBIOTIC USE AND THEIR RESISTANCE IN PATIENTS ADMITTED IN ICU
Prevalence of antibiotic consumption is high in critically ill patients. Besides of its economic impact, there is a chance of delayed diagnosis, difficulties in identifying causative microorganisms and the constant threa...